Medindia

X

VIIHEALTH subsidiary Argolife Launches MCM Builder, Multi-Channel Digital Content Builder, at Veeva Commercial Summit 2016, Madrid, Nov 29-Dec 1, 2016

Tuesday, November 15, 2016 Corporate News J E 4
Advertisement
Enabling "On the Fly" Multi-Channel Targeted Digital Content Updates

PHILADELPHIA, Nov. 14, 2016 /PRNewswire/ -- Argolife SAS, a subsidiary of viihealth, Inc., a next-generation digital customer engagement solutions provider for the Life Science industry, announces commercial release of MCM Builder™, its cloud-based SaaS solution to quickly and cost-effectively build and update multi-channel digital content.Currently, over 90% of pharma reps worldwide are equipped with an iPad, but few use them regularly in professional detailing. In an increasingly complex digital environment, the question for many bio-pharma marketers is "How can I optimize targeted digital content for the field and all other channels to drive better customer engagement and business results?"By using the state of the art MCM Builder™, bio-pharma has demonstrated a multi-fold increase in field sales-force utilization of iPads; and over 50% reduction in time, agency hours and costs to develop and localize content for healthcare professionals ("HCPs").MCM Builder™ works seamlessly with Veeva iRep and other CLM ecosystems, enabling Life Science companies to easily improve and streamline digital content updates "on the fly" -- without the need for cumbersome, costly manual programming. viihealth, through Argolife, is the only Veeva partner with the highest Veeva Level IV certification and a global cloud-based content authoring solution. The new MCM Builder™ offers multiple exciting capabilities, including the following:

  • Create, edit & export presentations in Veeva native formats (both deep and wide content)
  • Manage references and dynamic call flows
  • Add dynamic surveys and branching logic within digital presentations
  • Full analytic and KPI tracking, versioning and user access control
  • Easily duplicate and share materials with affiliates or other groups within the organization
  • Create and visualize multi-channel campaigns
  • Enable affiliates to easily adapt and localize global and regional campaigns effortlessly

"Importantly, the MCM Builder™ helps clients deliver fresh, timely, customer-tailored content right where it's needed most:  in the hands of the field rep," commented Argolife President, Mr. Jean-Michel Renodau. The SaaS solution will be proudly showcased at the Veeva EU Commercial Summit 2016, Madrid, starting November 29, 2016. Key team members will be onsite addressing questions, providing consultation, and interacting with distinguished partners and clients. "As a leader in digital customer engagement, we are excited to help all of our clients generate higher returns on marketing investment across each and every channel," confirmed Mark Benthin, Co-Founder and Chairman of viihealth.About viihealth, Inc.viihealth, Inc. is a next-generation digital customer engagement company that adds unique value for the global life science industry through targeted, scalable and smart cloud-based solutions – software, services, and data – that seamlessly work with leading established enterprise platforms, bridging the gaps to improve marketing and sales impact. www.viihealth.comMedia Contact:viihealth, Inc., Kathy Winder215-352-3400kwinder@viihealth.com

PRLog ID: www.prlog.org/12601278

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/viihealth-subsidiary-argolife-launches-mcm-builder-multi-channel-digital-content-builder-at-veeva-commercial-summit-2016-madrid-nov-29-dec-1-2016-300362314.html

SOURCE viihealth, Inc.

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Marapharm Ventures Inc. (Marapharm) Provides an Up...
S
Senhwa Biosciences Files New Patent Applications f...